Neoadjuvant radiochemotherapy for patients with locally advanced rectal cancer leads to impairment of the anal sphincter.
Theisen
Joerg
J
Department of Surgery, Klinikum Rechts der Isar, Technische Universität Muenchen, Ismaningerstrasse 22, 81675 Munich, Germany. theisen@nt1.chir.med.tu-muenchen.de
Kauer
Werner K-H
WK
Nekarda
Hjalmar
H
Schmid
Ludwig
L
Stein
Hubert J
HJ
Siewert
Joerg-Ruediger
JR
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001003:Anal Canal / Q000187:drug effects / Q000503:physiopathology* / Q000528:radiation effects; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005242:Fecal Incontinence / Q000209:etiology; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008365:Manometry; D008875:Middle Aged; D009119:Muscle Contraction / Q000502:physiology; D020360:Neoadjuvant Therapy; D011312:Pressure; D011879:Radiotherapy Dosage; D012004:Rectal Neoplasms / Q000188:drug therapy / Q000532:radiotherapy* / Q000601:surgery; D016896:Treatment Outcome
D000964:Antimetabolites, Antineoplastic; D000970:Antineoplastic Agents; D005472:Fluorouracil